跳至主要内容
临床试验/CTRI/2022/06/043067
CTRI/2022/06/043067尚未招募2 期

Evaluation Of Effect Of Nisha Amalaki Churna With Ghrit-Madhu Anjan In Comparison With Nisha Amalaki Churna In Non-Proliferative Diabetic Retinopathy (Npdr) â?? An Open Labeled Randomised Controlled Clinical Study

Dean Parul Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Those who are fit for Anjana
  • Patient having symptoms of Non proliferative diabetic retinopathy.
  • All Patients suffering from Diabetes.
  • Those who give consent, as per requirement.
  • Patient having age between 25 to 70 year

排除标准

  • Patients with ocular manifestations due to serious systemic illness like metastatic
  • carcinoma etc.
  • Patient underwent any of the ophthalmic surgeries in past six months.
  • Those contraindicated for Anjana.
  • Autoimmune diseases like Gillian barre syndrome, multiple sclerosis etc.
  • Post cataract Surgery & any other post-operative complication.
  • Patients with contagious diseases like AIDS etc.

研究者

发起方
Dean Parul Institute of Ayurveda

相似试验